Not for long. There are a lot of similar drugs, some already on the market and others in the pipeline. Recent clinical trials have shown that Eli Lilly's Zepbound (tirzepatide) is superior to Novo Nordisk's Wegovy (semaglutide).

https://investor.lilly.com/news-releases/news-release-detail...